Skewed X-chromosome inactivation in human miscarriages


Cite item

Full Text

Open Access Open Access
Restricted Access Access granted
Restricted Access Subscription Access

Abstract

The sex ratio in the first trimester of pregnancy shifts toward males due to increased elimination of female embryos. One reason for this phenomenon may be disruption of X chromosome inactivation. In this paper, we have analyzed the nature of the X chromosome inactivation in extraembryonic tissues of induced and spontaneous abortuses with 46,XX karyotype. Both equiprobable and asymmetric inactivation have been found in chorionic cytotrophoblast from spontaneous and induced abortuses. In the extraembryonic mesoderm of the control group of embryos, only equiprobable inactivation has been found, whereas this parameter was shifted in 15% of spontaneous abortions. The highest incidence of the selective inactivation of one of the parent homologues was found in the group with a lack of development of embryos and embryos from women with recurrent miscarriages. One of the reasons for the observed results can be compartmentalization of cells in the blastocyst leading to the nonrandom redistribution of cells and the predominance in the inner mass of cells with an active X chromosome with aberrations incompatible with normal embryonic development.

About the authors

S. A. Vasil’ev

Research Institute of Medical Genetics; National Research Tomsk State University

Email: kate.tolmacheva@medgenetics.ru
Russian Federation, Tomsk, 634050; Tomsk, 634050

E. A. Sazhenova

Research Institute of Medical Genetics

Email: kate.tolmacheva@medgenetics.ru
Russian Federation, Tomsk, 634050

D. I. Zhigalina

National Research Tomsk State University

Email: kate.tolmacheva@medgenetics.ru
Russian Federation, Tomsk, 634050

E. I. Grigorovich

National Research Tomsk State University

Email: kate.tolmacheva@medgenetics.ru
Russian Federation, Tomsk, 634050

T. V. Nikitina

Research Institute of Medical Genetics

Email: kate.tolmacheva@medgenetics.ru
Russian Federation, Tomsk, 634050

A. A. Mel’nikov

Research Institute of Medical Genetics

Email: kate.tolmacheva@medgenetics.ru
Russian Federation, Tomsk, 634050

E. S. Zhabina

Siberian State Medical University of the Russian Ministry of Health

Email: kate.tolmacheva@medgenetics.ru
Russian Federation, Tomsk, 634050

T. V. Ivanova

Siberian State Medical University of the Russian Ministry of Health

Email: kate.tolmacheva@medgenetics.ru
Russian Federation, Tomsk, 634050

I. D. Evtushenko

Siberian State Medical University of the Russian Ministry of Health

Email: kate.tolmacheva@medgenetics.ru
Russian Federation, Tomsk, 634050

I. N. Lebedev

Research Institute of Medical Genetics; National Research Tomsk State University; Siberian State Medical University of the Russian Ministry of Health

Email: kate.tolmacheva@medgenetics.ru
Russian Federation, Tomsk, 634050; Tomsk, 634050; Tomsk, 634050

E. N. Tolmacheva

Research Institute of Medical Genetics; National Research Tomsk State University

Author for correspondence.
Email: kate.tolmacheva@medgenetics.ru
Russian Federation, Tomsk, 634050; Tomsk, 634050

Supplementary files

Supplementary Files
Action
1. JATS XML

Copyright (c) 2016 Pleiades Publishing, Ltd.